MiR-152-3p might also act as a tumor suppressor in human breast cancer cells via negatively regulating PIK3CA expression to inhibit the activation of AKT and RPS6, leading to the suppression of HCC1806 cells proliferation40. Here, RPS6 is linked to neoplasm.